Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
about
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightPathophysiology of Non Alcoholic Fatty Liver DiseaseThe effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.Autophagy and its link to type II diabetes mellitusThe potential of phototherapy to reduce body fat, insulin resistance and "metabolic inflexibility" related to obesity in women undergoing weight loss treatment.Elevated circulating irisin is associated with lower risk of insulin resistance: association and path analyses of obese Chinese adults.miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels.Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal musclePhysical activity and liver diseases.Exercise and the Regulation of Hepatic Metabolism.Nonalcoholic fatty liver disease: Evolving paradigms.Synergistic effect of Carnosine on Browning of Adipose Tissue in Exercised Obese Rats ; A Focus on Circulating Irisin Levels.Non-alcoholic Fatty Liver Disease: A Clinical Update.Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling.Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg-Ay/J mice and a Taiwanese Han Chinese population.Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosisSerum and Adipose Tissue mRNA Levels of ATF3 and FNDC5/Irisin in Colorectal Cancer Patients With or Without Obesity
P2860
Q26752583-3801EA44-4EE1-4904-B50B-A72942567F62Q28070011-4B362100-1D78-49E0-9BFC-0C11EEB61134Q33776388-DF96D6B2-1792-4497-B5BD-E46933221A47Q33821526-345A4ED3-90AC-409C-AE4F-392E51B90527Q35721173-8FC052E2-5D40-4324-80B3-AB271E4D4ED7Q36090017-A69B305B-DBDA-444F-BD9F-C28A60D6465AQ36504308-AEF28680-1599-4E2D-BF0A-FE640C5F1B8FQ37242858-E708A337-66AA-4965-9E56-9AA892C222BEQ37703491-7A14323D-9338-4BC3-BCCA-B8176A0D50B6Q38574957-3F594EA7-FB13-4231-B6CA-DF6AD0DC3277Q38610393-3ECBB98F-0607-4AA6-9415-4A3A91D21E62Q42695154-9DB1B519-5C96-4293-B5B4-064998C5C097Q46242209-BF7FBA10-AB21-4DB4-934B-6CAFE940D4C3Q47100244-4DC7F9F0-D17B-4790-B9BB-348986843F90Q47665013-4335315D-A8DE-4AA1-90CD-19BC95C3254DQ55092383-F840038D-9A7F-4E35-8666-9943E39CF628Q57483541-B4345293-AADE-4438-817F-5DE37E709B4EQ58754098-A73726DD-E4A3-4217-95AA-51A0C9C159F6
P2860
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@ast
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@en
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@nl
type
label
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@ast
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@en
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@nl
prefLabel
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@ast
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@en
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@nl
P2093
P2860
P50
P921
P356
P1476
Irisin, a link among fatty liver disease, physical inactivity and insulin resistance.
@en
P2093
Isidora Ranchal
Javier Crespo
Manuel Romero-Gómez
María Teresa Arias-Loste
P2860
P304
23163-23178
P356
10.3390/IJMS151223163
P407
P5008
P577
2014-12-12T00:00:00Z